(Q43691230)
Statements
1 reference
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study (English)
1 reference
Masatoshi Kudo
1 reference
Abhasnee Sobhonslidsuk
1 reference
Philip J Johnson
1 reference
Shukui Qin
1 reference
Joong-Won Park
1 reference
Ronnie T P Poon
1 reference
Jean-Luc Raoul
1 reference
Philip A Philip
1 reference
Chih-Hung Hsu
1 reference
Tsung-Hui Hu
1 reference
Jeong Heo
1 reference
Jianming Xu
1 reference
Ligong Lu
1 reference
Yee Chao
1 reference
Eveline Boucher
1 reference
Kwang-Hyub Han
1 reference
Seung-Woon Paik
1 reference
Jorge Robles-Aviña
1 reference
Lunan Yan
1 reference
Dmitry Komov
1 reference
Thomas Decaens
1 reference
Won-Young Tak
1 reference
Long-Bin Jeng
1 reference
David Liu
1 reference
Rana Ezzeddine
1 reference
Ian Walters
1 reference
Ann-Lii Cheng
1 reference
26 August 2013
1 reference
1 reference